Synagis palivizumab 100mg/1 mL Single-Dose VialSynagis is the only FDA approved monoclonal antibody to help protect high risk infants against RSV. Synagis palivizumab 100mg 1 mL Single Dose Vial is a highly effective medication used to prevent serious respiratory infections in infants and young children caused by the respiratory syncytial virus (RSV). RSV is the most common cause of bronchiolitis and pneumonia in children under the age of one, making it a significant health concern for parents and

Serious adverse effects are rare but can occur: notable risks include hepatotoxicity (liver damage) and cardiac arrhythmias (QT prolongation)

which helps to reduce the size of the hernia and to keep it from getting worse

Ester C 500 mg

Ultra-Fine 31 Gauge Needle (6mm): For minimal pain

including acne scars

NDC: 63323-407-03

and can also be used at home for wound care or the management of medical devices

50 Per Box for Respiratory Therapy

built-in bacteria filter

Order Gauze Pads 2 x 2 Sterile 12 Ply 100/box online or call to speak with a trained representative today

Leading brand in insulin injection technology

providing relief for dryness